Addition of SRL 172 to standard chemotherapy in small cell lung cancer (SCLC) improves symptom control
Harper-Wynne, C.L., Sumpter, K., Ryan, C., Priest, K., Norton, A., Ross, P., Ford, H.E.R., Johnson, P., O’Brien, M.E.R.Volume:
47
Language:
english
Journal:
Lung Cancer
DOI:
10.1016/j.lungcan.2004.08.013
Date:
February, 2005
File:
PDF, 59 KB
english, 2005